U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 5

1.
Figure 4

Figure 4. From: Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression.

This figure represents the percentage of expressed proteins according to their cellular function.

Charles F. Streckfus, et al. J Oncol. 2012;2012:413256.
2.
Figure 2

Figure 2. From: Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression.

This figure demonstrates the differences in salivary protein profiles between HER2/neu -positive and HER2/neu -negative samples. Please change.

Charles F. Streckfus, et al. J Oncol. 2012;2012:413256.
3.
Figure 1

Figure 1. From: Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression.

This figure illustrates the protein profiles for HER2/neu-receptor-positive and HER2/neu-receptor-negative samples. As shown in the far right red and green dyed gel comparisons, there are numerous differences between the two profiles.

Charles F. Streckfus, et al. J Oncol. 2012;2012:413256.
4.
Figure 3

Figure 3. From: Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression.

The figure represents the natural logarithm differential expression of salivary proteins. To the right and left of the figure listed in rank order of expression are the up- and downregulated proteins, respectively.

Charles F. Streckfus, et al. J Oncol. 2012;2012:413256.
5.
Figure 5

Figure 5. From: Salivary Protein Profiles among HER2/neu-Receptor-Positive and -Negative Breast Cancer Patients: Support for Using Salivary Protein Profiles for Modeling Breast Cancer Progression.

It illustrates the presence of profilin-1 in the SKBR3 and HSG cell lysates and saliva sampled from healthy, benign, and malignant tumor patients. Profilin is a downregulated protein in the presence of malignancy, and it is visualized by the lighter bands associated with malignancy. It is also worth noting that the Her2/neu-receptor-negative band is darker than the Her2/neu-receptor-positive counterpart suggesting further downregulation of the profiling-1 protein.

Charles F. Streckfus, et al. J Oncol. 2012;2012:413256.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center